Funder
Shanghai Institute of Materia Medica
Chinese Academy of Sciences for Innovative Pharmaceutical
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference25 articles.
1. A rationale for determining testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity;Muller;Regul. Toxicol. Pharmacol.,2006
2. Guideline on the Limits of Genotoxic Impurities,2006
3. Genotoxic and Carcinogenic Impurities in Drug Substances and Products. Recommended Approaches,2008
4. ICH Guideline M7(R1) Assessment and Control of DNA Reactive (mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk,2017
5. A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances;An;J. Pharm. Biomed. Anal.,2008